The Effect of Cyclodextrin Inclusion Complexation on the in Vitro Protein Binding and in Vivo Prothrombin Time of Warfarin
- 1 January 1987
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 13 (2) , 329-343
- https://doi.org/10.3109/03639048709040176
Abstract
That the inclusion complexation occurred in an aqueous solution was proved by solubility determination and a membrane permeation study. The effects of inclusion complexation on the protein binding and prothrombin time of warfarin were studied by the technique of ultrafiltration and prothrombin time measurements respectively. The apparent stability constant of 1:l complex was obtained from the initial portion of the straight line of phase solubility diagrams. The apparent stability constant of α or β - cyclodextrin complex is 10.29 M -1 or 148.88 M-1. The greater the stability constant of the inclusion complex the less the permeability of the warfarin. The magnitude of the stability constant of the inclusion complex also determined the protein binding and the prothrombin time of warfarin. The greater the stability constant of the inclusion complex, the lesser the protein binding and the more prolonged the prothrombin time of warfarin. β-cyclodextrin showed a significantly different behavior from α-cyclodextrin in vitro protein binding and in vivo prothrombin time. The present results indicate a greater stability constant of the inclusion complex formed might determine the binding of warfarin to ablbumin and lead to an increased anticoagulant activity of warfarin.This publication has 12 references indexed in Scilit:
- Interaction between warfarin and nonsteroidal anti-inflammatory drugs (NSAIDs) in ratsLife Sciences, 1985
- Improvement of dissolution and absorption characteristics of benzodiazepines by cyclodextrin complexationInternational Journal of Pharmaceutics, 1983
- Inclusi on complexations of steroid hormones with cyclodextrins in water and in solid phaseInternational Journal of Pharmaceutics, 1982
- Pharmaceutical Applications of Cyclodextrin ComplexationsYAKUGAKU ZASSHI, 1981
- Cyclodextrin Inclusion Compounds in Research and IndustryAngewandte Chemie International Edition in English, 1980
- Effect of coadministration of aluminum and magnesium hydroxides on absorption of anticoagulants in manClinical Pharmacology & Therapeutics, 1973
- In Vivo and In Vitro Availability of Commercial Warfarin TabletsJournal of Pharmaceutical Sciences, 1971
- The effect of various drugs on the binding of warfarin-14C to human albuminBiochemical Pharmacology, 1967
- Physicochemical and Physiologic Factors Affecting the Absorption of Warfarin in ManJournal of Pharmaceutical Sciences, 1966
- Interaction of Pharmaceuticals with Schardinger Dextrins IJournal of Pharmaceutical Sciences, 1963